|
contents | europe | ||||
| Only 6 Weeks until Investment In Innovation (In3) Europe in Paris Medtech Insight, a division of Windhover Conferences-Investors and large company partners such as Abbott Laboratories, Abingworth Management Ltd., Bard Ltd., Boston Scientific EarlyBird Ventures, Edmond de Rothschild Investment Partners, Edwards Lifesciences Corporation, Kimberly-Clark Health Care, Matignon Technologies FCPR, Medtronic Europe Sarl, Paul Capital Partners, Pitango Venture Capital, Rothschild Gestion-Paris, Sanofi-Aventis Deutschland GmbH, Sofinnova Partners and more have already decided to send their teams to Europe's best strategic partnering and investment event. "Investment In Innovation (In3) Europe" conference, being held April 29-30, 2009 at The Marriott Rive Gauche Hotel in Paris, France, is a do-not-miss worldwide med device event for those looking to partner, invest and network with the most promising medical technology companies. Presenting companies to date (with many presenting at an In3 event for the first time) include Cardio³ Biosciences SA, Cardiola, Ltd., Invendo Medical GmbH, Lifenova Biomedical SA, Medical Device Works, Miracor Medical Systems GmbH, mNemoScience GmbH, MTM Laboratories, Nanobiotix, NOLabs AB, Photo Dynamic Therapy, PolyMedix, Inc., Sensile Medical AG, Symetis SA, ThermopeutiX, Inc., Vittamed, and Vivostat A/B, among many others being added to the program regularly. A presenting company product exhibition and networking reception will take place on Wednesday evening, April 29th. A panel discussion titled "Trends in European Dealmaking and Investing" showcases several investors that provide unconventional wisdom on the issues faced by today's medical device players, big and small - from identifying hot clinical areas to understanding the changing funding environment to assessing the current state of M&A and IPO's, as well as looking at market adoption trends and evolving device business models in Europe. Panelists include Antoine Papiernik, Managing Partner, Sofinnova Partners, Dr. Thierry Chignon, Partner, Matignon Investissement & Gestic, Ruti Alon, General Partner, Pitango Venture Capital and Timothy Haines, Partner, Abingworth Management Ltd. The "State of the Medical Device Industry Address" by Medtech Insight/Windhover's Device Editorial Team will take place with speakers to include David Cassak, Managing Director, Windhover Information, Stephen Levin, Executive Editor, FDC Windhover, and Tom Salemi, Staff Writer, IN VIVO, STARTUP will begin on April 30th. The second interactive panel discussion will be held on Thursday morning, April 30th entitled "Best Practices and Lessons from the Front Lines: CEOs Talk about Building Successful Companies in Europe Today" with panelists to include Kevin Sidow, CEO, Moximed, Tor Peters, Executive Chairman, Occlutech AB and Lawrence Kinet, Group CEO, LMA International. In3 Europe sponsors include AdvaMed, Life Science Intelligence, MDMA, MTB Europe, Ronald Trahan Associates, and FDC Reports' The Gray Sheet. Medtech Insight and its parent company Windhover Conferences, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1600 emerging medical technology company presenters and over 8000 attendees have participated at In3 events over the past 8 years. Medtech Insight and Windhover Conferences will also hold the upcoming "Investment In Innovation (In3) East" and "Medical Device Investor Day" being held prior to "Investment In Innovation (In3) East" conference at The Westin Copley Place in Boston, MA, June 23-25, 2009. For more information on these investment and partnering events, please contact Medtech Insight. write your comments about the article :: © 2009 Exhibition News :: home page |